Resources & Guides
Educational content about GLP-1 medications, pharmacokinetics, and optimizing your treatment journey.
GLP-1 Medication Hubs
Comprehensive guides for each GLP-1 medication—dosing protocols, clinical trial data, microdosing strategies, and our free calculators.
Semaglutide Guide
Ozempic & Wegovy: GLP-1 receptor agonist. ~15% weight loss, 7-day half-life. FDA-approved for diabetes and weight management.
Tirzepatide Guide
Mounjaro & Zepbound: Dual GLP-1/GIP agonist. ~21% weight loss, 5-day half-life. The first dual-agonist approved by FDA.
Retatrutide Guide
Triple GLP-1/GIP/Glucagon agonist. ~24% weight loss in trials, 6-day half-life. Expected FDA approval 2027.
Educational Content
GLP-1 Side Effects: Retatrutide, Tirzepatide & Semaglutide Compared
guideRetatrutide side effects guide: nausea, diarrhea, and other GI symptoms from Phase 2 clinical trial data, plus management strategies.
GLP-3 Retatrutide Explained: Why the Nickname and What It Is
articlePeople search "GLP-3 retatrutide" after hearing the nickname online. There is no GLP-3 receptor. Retatrutide is a triple agonist hitting GLP-1, GIP, and glucagon. Here is where the name came from and what it means.
What Does Retatrutide Do? Plain-Language Effects on Your Body
articleRetatrutide activates three hormone receptors at once. Here is what it actually does inside the body: appetite suppression, metabolic shifts, blood sugar regulation, and fat loss, all grounded in published Phase 2 data.
Retatrutide Dosage Chart: 2mg to 12mg Week-by-Week Schedule
guidesComplete GLP-3 retatrutide dosage chart showing the Phase 2/3 clinical trial titration from 2mg to 12mg weekly. Includes what to expect at each dose, weight loss results by tier, side effects data, printable download, and free dosing calculator.
Retatrutide Weight Loss: Results, Timeline & What to Expect
guidesHow much weight can you lose on retatrutide? This guide covers Phase 3 and Phase 2 clinical data, a month-by-month timeline, cross-drug comparison to tirzepatide and semaglutide, body composition breakdown, and what individual factors affect your results.
Retatrutide Guide: Dosing, Results, Calculator & Side Effects (2026)
hubThe ultimate retatrutide resource hub. Learn about this investigational triple-agonist, its remarkable Phase 2 results, dosing schedules, microdosing protocols, and use our free calculator to plan your journey.
Retatrutide Cost: $150 to $1,500/mo by Source (2026 Prices)
articleRetatrutide has no official price. It's still in Phase 3 clinical trials. This guide covers what people actually pay today for research peptides and compounded retatrutide, what it will likely cost at commercial launch, and how it compares to tirzepatide and semaglutide.
How Does Retatrutide Work? The Triple Agonist Mechanism Explained
articleRetatrutide is the first triple agonist that activates GIP, GLP-1, and glucagon receptors at once. How each receptor contributes to weight loss, why it outperforms single and dual agonists, and what the clinical data shows.
What Is Retatrutide? Complete Guide to the Triple-Agonist Weight Loss Drug
articleRetatrutide is an investigational triple-agonist medication that activates GLP-1, GIP, and glucagon receptors. Phase 2 trials showed 24.2% weight loss, the highest ever recorded for a GLP-1 class drug. Learn everything about this breakthrough medication.